Viking Therapeutics Inc buy melinda
Start price
26.06.17
/
50%
€0.97
Target price
14.09.17
€1.17
Performance (%)
11.19%
End price
14.09.17
€1.07
Summary
This prediction ended on 14.09.17 with a price of €1.07. The BUY prediction by melinda finished with a performance of 11.19%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Viking Therapeutics Inc | 4.288% | 4.288% | 27.361% | 134.423% |
| iShares Core DAX® | -2,68 % | 4,26 % | 2,12 % | 57,51 % |
| iShares Nasdaq 100 | 0,73 % | 5,80 % | 34,20 % | 92,83 % |
| iShares Nikkei 225® | -0,73 % | 9,32 % | 61,30 % | 80,34 % |
| iShares S&P 500 | 1,17 % | 5,48 % | 24,75 % | 70,97 % |
Comments by melinda for this prediction
In the thread Viking Therapeutics Inc diskutieren
VK5211 akute Hüftfraktur
Phase - 2 - Daten im Spätsommer der Ankunft 2017
Stopped prediction by melinda for Viking Therapeutics Inc
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€15.53
30.03.23
30.03.23
-
30.03.24
30.03.24
27.01%
31.05.23
31.05.23
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€9.36
03.04.19
03.04.19
€13.53
04.11.21
04.11.21
-44.07%
21.12.20
21.12.20
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€11.15
19.11.18
19.11.18
€13.53
22.01.19
22.01.19
-33.23%
22.01.19
22.01.19
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€5.68
27.02.18
27.02.18
€6.31
31.05.18
31.05.18
27.94%
31.05.18
31.05.18
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€5.85
11.02.18
11.02.18
€6.31
22.02.18
22.02.18
10.94%
22.02.18
22.02.18
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€2.16
10.11.17
10.11.17
€4.51
13.11.17
13.11.17
13.88%
13.11.17
13.11.17
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€2.40
10.11.17
10.11.17
€5.00
13.11.17
13.11.17
13.88%
13.11.17
13.11.17